Technology News and Research

RSS

Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients

Antares Pharma, Inc. announced today positive results from its Phase 3 study of Anturol Gel in patients with overactive bladder. The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied.

28 Jul 2010

IntriCon second-quarter net sales increase 16.6% to $14.9 million

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical devices, today announced financial results for its second quarter ended June 30, 2010.

28 Jul 2010

GE Healthcare completes new $15 million medical technology manufacturing facility in Cardiff, Wales

Life sciences giant GE Healthcare has opened a $15 million medical technology manufacturing facility in Cardiff, Wales. The new facility is based at the 30-acre Maynard Centre, where the company already employs over 400 people.

28 Jul 2010

Antigenics announces positive results of AG-707 genital herpes vaccine

Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.

28 Jul 2010

Research on method to open blood-brain barrier for safe cancer drug delivery

One of the human body's most powerful defensive tools, the blood-brain barrier is a chemical labyrinth that prevents toxins and viruses in the bloodstream from reaching the brain. This foolproof security system, however, limits the ability of physicians to deliver drugs directly to the brain, making it difficult to treat brain tumors. Researchers at Rensselaer Polytechnic Institute are endeavoring to solve this problem by investigating new methods for bypassing the blood-brain barrier and combating the spread of brain cancer.

28 Jul 2010

MabCure's MAbs 94% accurate in identifying ovarian cancer

Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.

28 Jul 2010

Scientists develop novel chemotherapeutic method for anticancer drug delivery

Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.

28 Jul 2010

Attaching transferrin to nanoparticle surface can kill cancer cells

A normally benign protein found in the human body appears to be able - when paired with nanoparticles - to zero in on and kill certain cancer cells, without having to also load those particles with chemotherapy drugs.The finding could lead to a new strategy for targeted cancer therapies, according to the University of North Carolina at Chapel Hill scientists who made the discovery.

28 Jul 2010

WWHI participates in joint meeting to explore barriers to wireless communications, health care solutions

The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.

27 Jul 2010

Growth in dental implant sales to propel bone-graft-substitute market

According to new dental reports by iData Research, the leading global authority in medical device, dental and pharmaceutical market research, the U.S. market for dental implants is expected to regain double-digit growth by 2013, and will help drive the dental prosthetic market to reach over 82 million prosthetic placements by 2016.

27 Jul 2010

MedClean Technologies announces support for The IMWTA with the launch of IMWTA.com

MedClean Technologies, the leading provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced its support for The IMWTA with the launch of IMWTA.com, an online portal to complement Barnett Medical Services' recent formation of the Independent Medical Waste Transporters Association designed to provide members significant exposure and resources to compete nationally.

27 Jul 2010

Quick-Med Technologies announces launch of new website

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, has recently launched a new website, www.quickmedtech.com, highlighting its innovative patented technologies.

27 Jul 2010

First Edition: July 27, 2010

Today's health policy news includes reports about the continuing Senate backlash to Dr. Donald Berwick's appointment to head the Center for Medicare and Medicaid Services as well as findings from a new poll that reveal seniors really don't understand health reform.

27 Jul 2010

Progenra receives Official Notice of Allowance for screening platform

Progenra, Inc., announced today their receipt of an Official Notice of Allowance, dated June 15, 2010, of U.S. Patent Application No. 11/156,707, "Diagnostic and Screening Methods and Kits Associated with Proteolytic Activity." IP protection of this technology was also recently granted by the European Union. This technology will enable faster drug discovery by improving the ability to identify more selective drugs that modulate the handling of proteins associated with various disease states.

27 Jul 2010

Thermo Fisher Scientific highlights products, services for clinical research and specialty diagnostics at AACC 2010

Thermo Fisher Scientific Inc., the world leader in serving science, will highlight its innovative offering of products and services for clinical research and specialty diagnostics during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo held in Anaheim, California, July 25 - 29, 2010.

From Thermo Fisher Scientific Inc. 27 Jul 2010

Kinetic Concepts second-quarter global revenue increases 1% to $497.8 million

Kinetic Concepts, Inc. today reported second quarter 2010 total revenue of $497.8 million, an increase of 1% from the second quarter of 2009 and up 2% from the first quarter of 2010. Total revenue for the first half of 2010 was $983.6 million, a 2% increase from the prior-year period. Unfavorable foreign currency exchange movements reduced total revenue for the second quarter of 2010 by less than 1%, while favorably impacting total revenue for the first six months of 2010 by 1% compared to the corresponding periods of the prior year.

27 Jul 2010

BK Medical appointed as sole agent for AMD's Prostate HistoScanning in UK

Advanced Medical Diagnostics SA, a privately held company committed to providing innovative computer-aided solutions (HistoScanning™) that can improve the diagnostic interpretation of ultrasound scans, today announced that it has appointed BK Medical UK Ltd as sole agent for Prostate HistoScanning™ in the UK.

27 Jul 2010

Encision reports 8% decline in first-quarter fiscal 2011 net sales

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its first fiscal quarter ended June 30, 2010.

27 Jul 2010

Data shows Exergen temporal artery thermometer outsells all other brands

The Exergen temporal artery thermometer outsells all other brands at retailers nationwide that stock the Exergen TemporalScanner, according to data compiled by leading market research firms. In comparing sales of all types of thermometers, including national brands and private label products, Nielsen and Information Resources Inc. found Exergen came out on top.

27 Jul 2010

USDA to facilitate virtual public discussion on power of telemedicine

Agriculture Under Secretary for Rural Development Dallas Tonsager announced late last week that the USDA will facilitate a virtual public discussion in the field of telemedicine. "The Power of Telemedicine" web discussion is an extension of the USDA's Open Government effort and Rural Development's latest effort to encourage a more widespread use and understanding of telemedicine.

27 Jul 2010